Literature DB >> 19057857

Familial hypertriglyceridemia.

Milind S Tullu1, Asmita V Advirkar, Radha G Ghildiyal, Shrinivas Tambe.   

Abstract

Familial hypertriglyceridemia (FHTG) is an uncommon primary (genetic) dyslipidemia. FHTG is characterized by moderately elevated serum triglycerides, usually in the absence of significant hypercholesterolemia and rarely manifests in childhood. We report an eight-month-old boy incidentally diagnosed as a case of FHTG due to lipemic serum (patient was admitted for malaria with anemia). He had elevated serum triglycerides with normal serum cholesterol, but had no symptoms related to the primary disorder (FHTG).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057857     DOI: 10.1007/s12098-008-0219-y

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  3 in total

1.  Common problems in the management of hypertriglyceridemia.

Authors:  Michelle A Fung; Jiri J Frohlich
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

2.  Management of Hyperlipidemia in the Pediatric Population.

Authors:  Serena Tonstad; Gilbert R. Thompson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10

3.  Plasma lipoproteins, apolipoproteins, and triglyceride metabolism in familial hypertriglyceridemia.

Authors:  A F Stalenhoef; P N Demacker; J A Lutterman; A van 't Laar
Journal:  Arteriosclerosis       Date:  1986 Jul-Aug
  3 in total
  3 in total

1.  Hypertriglyceridemia.

Authors:  Amanda Brahm; Robert A Hegele
Journal:  Nutrients       Date:  2013-03-22       Impact factor: 5.717

2.  Moyamoya Disease with Coexistent Hypertriglyceridemia in Pediatric Patient.

Authors:  Jacqueline Chan; Fabiola D'Ambrosio Rodriguez; Deepank Sahni; Claudia Boucher-Berry
Journal:  Case Rep Endocrinol       Date:  2016-10-24

Review 3.  Hypertriglyceridemia-induced acute pancreatitis in children: A mini-review.

Authors:  John M Grisham; Andrew H Tran; Kate Ellery
Journal:  Front Pediatr       Date:  2022-08-25       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.